Assessing Relapse in Multiple Sclerosis Questionnaire: Results of a Pilot Study

Table 3

Outcome for last relapse.

	Patients completing Part 1 of ARMS questionnaire (𝑁 = 103)
Time since last relapse, months
Mean (SD)	13.4 (12.0)
Range	0–36
Treatment for last relapse, 𝑛 (%)
Corticosteroids (IV or oral)	84 (82)
ACTH	5 (5)
Other, no treatment, or not sure	14 (14)
Effect of treatment on RSH, 𝑛 (%)	(𝑛 = 90*)
No improvement	1 (1)
A little	8 (9)
Somewhat	17 (19)
Very much	41 (46)
Returned to baseline	23 (26)
Mean (SD) RSH score	7.22 (2.5)

ACTH: adrenocorticotropic hormone; ADL: activities of daily living; ARMS: Assessing Relapse in Multiple Sclerosis; IV: intravenous; RSH: return to previous state of health; SD: standard deviation.
*Responses were not provided by 13 patients who reported no treatment or not sure of treatment for their last relapse.